Clemence Girardet

Title: Clemence Girardet: Innovator in Cognitive Treatment

Introduction

Clemence Girardet is a notable inventor based in Paris, France. He has made significant contributions to the field of cognitive health, particularly through his innovative patent related to cognitive decline. His work focuses on methods and compositions that aim to treat decreased cognitive ability in individuals.

Latest Patents

Clemence Girardet holds a patent for "Methods and compositions for treating decreased cognitive ability." This patent discloses methods and compositions for treating cognitive decline in subjects in need. More specifically, it details methods of administering exogenous adropin to subjects suffering from, or at risk of, cognitive decline. The patent also identifies subjects who would benefit from such treatment and includes pharmaceutical acceptable compositions comprising adropin and its derivatives or variations.

Career Highlights

Throughout his career, Girardet has worked with esteemed institutions such as Saint Louis University and the United States Government as represented by the Department of Veterans Affairs. His experience in these organizations has contributed to his expertise in cognitive health and treatment methodologies.

Collaborations

Clemence has collaborated with notable individuals in his field, including Andrew Alistair Butler and Susan Farr. Their combined efforts have furthered research and development in cognitive treatment.

Conclusion

Clemence Girardet's innovative work in treating cognitive decline showcases his dedication to improving mental health. His contributions through patents and collaborations highlight the importance of research in this critical area.